Lien Trinh
Pediatric Endocrinology · Orange, CANPI 1518082304
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations.
Across 101 payments — averaging $26.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$372
- AbbVie$244
- Ascendis Pharma Endocrinology Inc$216
- Dexcom, Inc.$169
- Novo Nordisk$151
- Tandem Diabetes Care, Inc.$145
- plus $1K from 27 others
Across 17 payments — averaging $7291.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurocrine Biosciences, Inc.$124K
What the payments were for
- Food & beverage$2,701100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 5 | $372 |
| AbbVie | 11 | $244 |
| Ascendis Pharma Endocrinology Inc | 6 | $216 |
| Dexcom, Inc. | 8 | $169 |
| Novo Nordisk | 6 | $151 |
| Tandem Diabetes Care, Inc. | 9 | $145 |
| Medtronic(2 entities) | 5 | $126 |
| Ipsen Biopharmaceuticals, Inc | 3 | $110 |
| Insulet Corporation | 4 | $104 |
| Rhythm Pharmaceuticals, Inc. | 4 | $99 |
| Lilly USA, LLC | 5 | $96 |
| Biomarin Pharmaceutical Inc. | 3 | $83 |
| Arbor Pharmaceuticals, Inc. | 4 | $80 |
| Eton Pharmaceuticals, Inc. | 2 | $76 |
| Pfizer | 3 | $56 |
| Amgen | 2 | $53 |
| Abbott | 2 | $53 |
| BETA Bionics, Inc. | 2 | $53 |
| AstraZeneca | 2 | $46 |
| BD | 1 | $42 |
| Azurity Pharmaceuticals, Inc. | 2 | $39 |
| Tolmar Pharmaceuticals, Inc. | 1 | $38 |
| Embecta Corp. | 1 | $29 |
| Zealand Pharma US, Inc. | 1 | $29 |
| Companion Medical, Inc. | 1 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Vistapharm, Inc. | 1 | $21 |
| Sanofi | 1 | $18 |
| Amphastar Pharmaceuticals, Inc. | 1 | $17 |
| Aegerion Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CRENESSITY$126
How this compares
$2,701 in reported general payments places this provider in the 65th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in Orange
- Lynda PolgreenOrange$167K
- Timothy FlanneryOrange$32K
- Himala KashmiriOrange$5K
- Daina DreimaneOrange$3K
- Nikita ForghaniOrange$3K
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
- Kevin KaisermanWest Covina$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.